Clinical trials
Not yet recruiting Phase 1/2 Triple Negative Breast Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2025 | 2 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| BioLite, Inc. | 1 |
| BreakBio Corp | 1 |
| CoRegen, Inc. | 1 |
| Harbin Medical University | 1 |
| Iovance Biotherapeutics, Inc. | 1 |
| National University Hospital, Singapore | 1 |
| Nova Scotia Health Authority | 1 |
| Ohio State University Comprehensive Cancer Center | 1 |
| Telomir Pharmaceuticals, Inc. | 1 |
| Texas Tech University Health Sciences Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 12 |
| Breast Neoplasms | 5 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Central Nervous System Diseases | 1 |
| Colorectal Neoplasms | 1 |
| Neoplasm Metastasis | 1 |
| Neoplasms | 1 |
| Prostatic Neoplasms | 1 |
| Recurrence | 1 |
| Squamous Cell Carcinoma of Head and Neck | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.